Search

everythinglearnresearchcommunity

for

Search:↓

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Early detection of specific skin lesions can help identify Birt-Hogg-Dube syndrome and prevent serious complications.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Quercetin may help improve symptoms of polycystic ovary syndrome.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Some women with PCOS have rare genetic variants linked to the condition.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Early diagnosis and personalized treatment are crucial for managing PCOS and preventing complications.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.